Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  vincristine sulfate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 1670 for your search:
Start Over
Prevention of CHOP-induced Chronic Cardiotoxicity
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 15 to 70
Sponsor: Other
Protocol IDs: OLSG-0401, NCT00162955
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: LAL-Ph-2000, NCT00526305
LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 and under
Sponsor: Other
Protocol IDs: LAL-AR-N-2005, NCT00526409
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: RJ-2010-56, NCT01358253
Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CHOP-Z, NCT01418430
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9802, CDR0000066367, E-R9802, NCCTG-R9802, SWOG-R9802, RTOG-DEV-1012, NCT00003375
Phase II-III Chemotherapy with BLEO/DTIC/VBL/ADR/PRED or NM/VCR/PCB/PRED Plus Radiotherapy for Advanced Hodgkin's Disease
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
Phase II-III VCR/PRED/L-ASP Induction, CNS Therapy plus MTX vs 6-MP/MTX vs 6-MP/MTX/CTX vs 6-MP/MTX/CTX/ARA-C for Pediatric ALL
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-ALL-TT-8
Phase II-III FAM (5-FU/ADR/MITO) vs V-FAM (FAM/VCR) vs Phase II Agent Chemotherapy for Advanced Gastric Adenocarcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7841
Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: WCCC-CO-7711R, NCI-D80-048-183
Phase II/III Timed Sequential Chemotherapy with CTX and VCR for Refractory or High-Risk Myeloma (Summary last modified 06/97)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-4480
Phase II-III Chemotherapy with High-Dose Methotrexate and Adriamycin plus Radiotherapy for Primary and Metastatic Osteogenic Sarcoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 and under
Sponsor:
Protocol IDs: CHOP-204
Phase II Chemotherapy with MTX/CF, Aminopterin or M-BACOD plus CTX or BCG Immunotherapy for Advanced non-Hodgkin's Lymphoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 25 to 65
Sponsor:
Protocol IDs: DFCI-75116
Phase II/III Pilot Combination Chemotherapy and Radiotherapy for Previously Untreated Childhood ALL with Poor Prognosis
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: CCG-192P
Phase II-III Chemotherapy with ADR/VCR/ARA-C plus Immunotherapy with BCG and Irradiated Cells for Acute Myelogenous Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: EORTC-LAM-4
Phase II/III L-PAM/PRED/VCR vs VP-16/PRED/ADR for Stage II/III Myeloma (Summary Last Modified 12/89)
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor:
Protocol IDs: SAFR-CT-MM-2
Phase II/III Randomized Comparison of PF (CACP/5-FU) vs MVPF (MITO/VCR/CACP/5-FU) in Advanced Large Bowel Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1285
Start Over